MR
Mujeeb Rahiman Ammu Ettamtharayil
About Mujeeb Rahiman Ammu Ettamtharayil
Data last updated:
Mujeeb Rahiman Ammu Ettamtharayil is a Designated Partner at Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp (since 2022), Director at Kajah Trading Private Limited (since 2004) and Designated Partner at Krg Pharma Llp (since 2025). The companies operate in Healthcare and FMCG. The 2 current companies with reported revenue have a combined latest revenue of ₹42.27 Cr; the largest is Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp at ₹35.37 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 11 Feb 2022 | 2017 | ₹35.37 Cr (FY 2019) | Active | |
 Kajah Trading Private Limited U51227PN2001PTC016010 | Director | 01 Apr 2004 | 2001 | ₹6.91 Cr (FY 2025) | Active |
| Krg Pharma Llp ACP-4548 | Designated Partner | 26 Jun 2025 | 2025 | Active |
Board colleagues of Mujeeb Rahiman Ammu Ettamtharayil
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mujeeb Rahiman Ammu Ettamtharayil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mujeeb Rahiman Ammu Ettamtharayil
Mujeeb Rahiman Ammu Ettamtharayil currently holds 3 directorships: Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp (Designated Partner, since 11 Feb 2022, revenue ₹35.37 Cr (FY 2019)); Kajah Trading Private Limited (Director, since 01 Apr 2004, revenue ₹6.91 Cr (FY 2025)); Krg Pharma Llp (Designated Partner, since 26 Jun 2025).
Mujeeb Rahiman Ammu Ettamtharayil was first appointed on 01 Apr 2004 as Director at Kajah Trading Private Limited. The most recent appointment on record is 26 Jun 2025 at Krg Pharma Llp.
The 2 current companies of Mujeeb Rahiman Ammu Ettamtharayil that report revenue have a combined latest revenue of ₹42.27 Cr: Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp ₹35.37 Cr (FY 2019); Kajah Trading Private Limited ₹6.91 Cr (FY 2025).
The current boards of Mujeeb Rahiman Ammu Ettamtharayil's companies include Abdul Baasit (Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp), Abdul Malik Arachamveettil (Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp), Abdul Raqeeb Aracham Veettil (Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp), Abdul Wadood Arachemveettil (Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp), Arachamveettil Abdul Haadi (Rajah Swast Aushadhi Seva Generic Medicine Distributor Llp), Abdul Azim (Kajah Trading Private Limited), among others.